Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at virkningen af Prometax på symptomerne på Alzheimers sygdom er beskeden, men at den hos nogle patienter er vigtig.
The Committee for Medicinal Products for Human Use (CHMP) concluded that Prometax has a modest effectiveness in treating the symptoms of Alzheimer’ s dementia, although this does reflect an important benefit in some patients.